BRIEF-Tempest Reports Year End 2025 Financial Results And Provides Business Update
Reuters03-30
BRIEF-Tempest Reports Year End 2025 Financial Results And Provides Business Update
March 30 (Reuters) - Tempest Therapeutics Inc TPST.O:
TEMPEST REPORTS YEAR END 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
TEMPEST THERAPEUTICS INC - APPOINTS MATT ANGEL AS CEO AND PRESIDENT
TEMPEST THERAPEUTICS INC - ANNOUNCES POSITIVE INTERIM DATA FROM REDEEM-1 PHASE 1/2A TRIAL OF TPST-2003
TEMPEST THERAPEUTICS INC - REPORTS NET LOSS OF $26.3 MILLION AND NET LOSS PER SHARE OF $6.33 FOR 2025
Source text: ID:nGNX54qKQ6
Further company coverage: TPST.O
((Reuters.Briefs@thomsonreuters.com;))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments